Enzon Pharmaceuticalsincis A Biotechnology Company Based In Piscatawaynew Jerseyfounded In 1981It Is Publicly Traded On Nasdaq Under The Tickerenzn The Company Primarily Operates As A Public Acquisition Vehiclefocusing On Leveraging Its Financial Structure For Strategic Opportunities Historicallyenzon Developed And Commercialized Therapeutics For Cancer And Life Threatening Diseasesincluding Notable Products Like Pegintronafor Hepatitis C And Oncasparafor Leukemiawhile It No Longer Engages In Active Drug Development Or Commercializationit Retains Royalty Rights From Its Legacy Productsthe Company Emphasizes Its Minimal Operational Expenses And Aims To Maintain Its Nasdaq Listing While Exploring Acquisition Opportunities
